Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
200 shown of 9,113 total abstracts
  1. Abstract 96482026-04-03 · 15:45 CT · S100A
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-462 study)
    S. Tolaney, T. Mok, M.C. Garassino, et al. · University of Chicago
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  2. Abstract 99742026-04-02 · 19:00 CT · Arie Crown Theater
    Quality of life outcomes with Tagrisso in patients with NSCLC
    L. Paz-Ares, S. Antonia, S. Tolaney, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  3. Abstract 98562026-04-05 · 19:00 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-247
    P. Schmid, S. Tolaney, M. Reck · Cleveland Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  4. Abstract 95712026-04-04 · 20:30 CT · Hall B1
    Quality of life outcomes with Keytruda in patients with SCLC
    S. Antonia, M.C. Garassino, S. Tolaney, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  5. Abstract 92622026-04-05 · 21:30 CT · E450
    Real-world effectiveness of Opdivo vs standard of care in NSCLC
    M. Krop, P. Schmid, H. Rugo · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  6. Abstract 97782026-04-02 · 18:45 CT · S406
    Quality of life outcomes with Imfinzi in patients with SCLC
    H. Rugo, S. Peters, R. Herbst · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  7. Abstract 99102026-04-01 · 20:00 CT · Hall B1
    FLAURA-287: Tagrisso (osimertinib) neoadjuvant in NSCLC
    F. Andre, C. Saura, J. Brahmer, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract 98232026-04-01 · 18:30 CT · S406
    FLAURA-790: Tagrisso (osimertinib) 1L in NSCLC
    E. Winer, J. Brahmer, C. Robert, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  9. Abstract LBA4008LBA2026-04-04 · 15:45 CT · Arie Crown Theater
    Long-term follow-up of Enhertu neoadjuvant for NSCLC: DESTINY-Breast-110
    F. Andre, P. Schmid, R. Herbst, et al. · MD Anderson Cancer Center
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  10. Abstract 97752026-04-03 · 20:15 CT · S100A
    Quality of life outcomes with Opdivo in patients with NSCLC
    M. Reck, J. Cortes · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  11. Abstract 92372026-04-03 · 20:30 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-554 study)
    S. Modi, T. Mok, J. Brahmer · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  12. Abstract 98252026-04-01 · 19:45 CT · S100A
    Long-term follow-up of Enhertu adjuvant for NSCLC: DESTINY-Breast-188
    J. Brahmer, H. Rugo · Karolinska Institute
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  13. Abstract LBA4012LBA2026-04-01 · 20:45 CT · S406
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-529
    H. Rugo, J. Brahmer, M.C. Garassino, et al. · National Cancer Center Japan
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  14. Abstract e120132026-04-02 · 15:00 CT · Hall B1
    Long-term follow-up of Imfinzi maintenance for SCLC: PACIFIC-158
    S. Tolaney, N. Rizvi, T. Mok, et al. · Stanford Cancer Institute
    Publication OnlyLung Cancer—Small Cell📄🖼️
  15. Abstract 92802026-04-03 · 19:15 CT · Hall B1
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-755 study)
    H. Rugo, M.C. Garassino, T. Mok · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  16. Abstract LBA4015LBA2026-04-01 · 16:45 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-285 study)
    S. Tolaney, P. Schmid, C. Robert, et al. · Chinese University of Hong Kong
    Late-Breaking Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  17. Abstract e120162026-04-04 · 15:15 CT · E450
    Long-term follow-up of Enhertu 2L for NSCLC: DESTINY-Breast-307
    F. Andre, M.C. Garassino · MD Anderson Cancer Center
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  18. Abstract 93422026-04-04 · 16:45 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-980 study)
    F. Andre, H. Rugo · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  19. Abstract 90842026-04-04 · 21:15 CT · E450
    DESTINY-Breast-76: Enhertu (trastuzumab deruxtecan) adjuvant in NSCLC
    S. Antonia, C. Saura, H. Rugo · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  20. Abstract 96622026-04-04 · 18:00 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-154
    H. Borghaei, L. Paz-Ares, J. Cortes · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  21. Abstract TPS80202026-04-04 · 14:15 CT · S100A
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-224 study)
    M. Krop, J. Cortes, F. Andre · Massachusetts General Hospital
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  22. Abstract 98952026-04-03 · 14:45 CT · Arie Crown Theater
    Long-term follow-up of Tecentriq neoadjuvant for NSCLC: IMpower-268
    C. Saura, M.C. Garassino · Massachusetts General Hospital
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  23. Abstract 93722026-04-05 · 16:30 CT · Hall B1
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-369
    J. Cortes, R. Herbst, M.C. Garassino, et al. · University of Chicago
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  24. Abstract 90842026-04-03 · 13:30 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-745 study)
    H. Rugo, J. Cortes, C. Robert, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  25. Abstract 97832026-04-01 · 15:15 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-496 study)
    S. Antonia, J. Cortes, H. Rugo · Institut Gustave Roussy
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  26. Abstract 99182026-04-01 · 15:15 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-337 study)
    N. Rizvi, M.C. Garassino, J. Brahmer, et al. · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  27. Abstract 97252026-04-03 · 13:30 CT · E450
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-238 study)
    G. Curigliano, E. Winer, T. Mok, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  28. Abstract 98382026-04-01 · 16:15 CT · S100A
    FLAURA-49: Tagrisso (osimertinib) neoadjuvant in NSCLC
    H. Rugo, M.C. Garassino, F. Andre, et al. · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  29. Abstract 97792026-04-02 · 19:15 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-16
    G. Curigliano, T. Mok, M. Krop, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  30. Abstract 95542026-04-04 · 19:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-418 study)
    H. Borghaei, E. Winer, S. Peters · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  31. Abstract 92412026-04-04 · 19:45 CT · S100A
    PACIFIC-330: Imfinzi (durvalumab) 3L+ in NSCLC
    S. Antonia, N. Rizvi, L. Paz-Ares · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  32. Abstract 95732026-04-03 · 15:30 CT · Arie Crown Theater
    Real-world effectiveness of Imfinzi vs standard of care in NSCLC
    R. Herbst, J. Brahmer, S. Modi, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  33. Abstract 92552026-04-02 · 20:15 CT · S406
    PACIFIC-923: Imfinzi (durvalumab) 3L+ in NSCLC
    M.C. Garassino, E. Winer · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  34. Abstract 93372026-04-01 · 20:45 CT · Arie Crown Theater
    Quality of life outcomes with Keytruda in patients with NSCLC
    S. Peters, E. Winer, P. Schmid, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  35. Abstract 91662026-04-05 · 15:45 CT · Arie Crown Theater
    Long-term follow-up of Tecentriq 1L for NSCLC: IMpower-400
    S. Antonia, L. Paz-Ares, T. Mok, et al. · Vall d'Hebron Institute of Oncology
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  36. Abstract LBA4035LBA2026-04-03 · 19:15 CT · S100A
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-858
    P. Schmid, M. Krop · MD Anderson Cancer Center
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  37. Abstract 90652026-04-03 · 15:15 CT · Hall B1
    Real-world effectiveness of Keytruda vs standard of care in SCLC
    G. Curigliano, L. Paz-Ares, J. Brahmer, et al. · National Cancer Center Japan
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  38. Abstract 99382026-04-02 · 14:15 CT · S100A
    Real-world effectiveness of Keytruda vs standard of care in NSCLC
    S. Peters, J. Cortes · Massachusetts General Hospital
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  39. Abstract 93872026-04-01 · 20:30 CT · E450
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-474 study)
    H. Borghaei, E. Winer, C. Saura · MD Anderson Cancer Center
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  40. Abstract 90822026-04-03 · 16:45 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-379
    T. Mok, N. Rizvi, M. Krop, et al. · Chinese University of Hong Kong
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  41. Abstract TPS80402026-04-01 · 21:45 CT · Arie Crown Theater
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-387
    M. Krop, P. Schmid · Karolinska Institute
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  42. Abstract 94842026-04-02 · 18:00 CT · S406
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-640
    S. Modi, H. Borghaei, E. Winer · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  43. Abstract 91992026-04-05 · 16:15 CT · Hall B1
    PACIFIC-681: Imfinzi (durvalumab) 1L in SCLC
    M.C. Garassino, J. Brahmer, M. Reck · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  44. Abstract e120432026-04-01 · 20:45 CT · E450
    KEYNOTE-461: Keytruda (pembrolizumab) 2L in SCLC
    R. Herbst, C. Robert · Memorial Sloan Kettering Cancer Center
    Publication OnlyLung Cancer—Small Cell📄🖼️
  45. Abstract 95392026-04-03 · 19:30 CT · Hall B1
    Quality of life outcomes with Imfinzi in patients with NSCLC
    H. Borghaei, P. Schmid, A. Spira, et al. · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  46. Abstract 90552026-04-01 · 18:00 CT · S100A
    Quality of life outcomes with Enhertu in patients with NSCLC
    N. Rizvi, S. Modi · Cleveland Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  47. Abstract 98552026-04-05 · 15:15 CT · Arie Crown Theater
    Real-world effectiveness of Tagrisso vs standard of care in NSCLC
    E. Winer, J. Brahmer, C. Robert, et al. · Massachusetts General Hospital
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  48. Abstract 90142026-04-01 · 20:30 CT · S100A
    Long-term follow-up of Tecentriq 3L+ for NSCLC: IMpower-726
    T. Mok, S. Peters · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  49. Abstract 95362026-04-05 · 20:30 CT · Arie Crown Theater
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-333
    H. Rugo, S. Peters, H. Borghaei, et al. · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  50. Abstract 96832026-04-05 · 14:30 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-217 study)
    A. Spira, L. Paz-Ares · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  51. Abstract 95122026-04-02 · 13:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-974 study)
    H. Rugo, T. Mok, P. Schmid, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  52. Abstract 97412026-04-04 · 20:30 CT · S100A
    FLAURA-128: Tagrisso (osimertinib) neoadjuvant in NSCLC
    L. Paz-Ares, M. Reck, R. Herbst · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  53. Abstract 96362026-04-04 · 18:15 CT · S406
    DESTINY-Breast-615: Enhertu (trastuzumab deruxtecan) 1L in NSCLC
    M. Krop, F. Andre, R. Herbst · Massachusetts General Hospital
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  54. Abstract 94312026-04-02 · 19:45 CT · S406
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-441
    A. Spira, T. Mok, C. Saura, et al. · University of Chicago
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  55. Abstract e120542026-04-03 · 16:45 CT · E450
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-128 study)
    N. Rizvi, T. Mok · Chinese University of Hong Kong
    Publication OnlyLung Cancer—Small Cell📄🖼️
  56. Abstract 98542026-04-02 · 19:15 CT · E450
    PACIFIC-254: Imfinzi (durvalumab) maintenance in NSCLC
    S. Tolaney, C. Robert · Royal Marsden Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  57. Abstract 97002026-04-05 · 18:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-588 study)
    S. Tolaney, F. Andre, R. Herbst, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  58. Abstract 93432026-04-01 · 20:15 CT · Hall B1
    KEYNOTE-634: Keytruda (pembrolizumab) 3L+ in NSCLC
    T. Mok, A. Spira, S. Modi, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  59. Abstract TPS80582026-04-05 · 16:15 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-55 study)
    S. Antonia, C. Saura, S. Modi · Royal Marsden Hospital
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  60. Abstract 99122026-04-02 · 18:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-192 study)
    P. Schmid, J. Cortes, S. Tolaney, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  61. Abstract 90242026-04-01 · 15:30 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-203
    A. Spira, L. Paz-Ares · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  62. Abstract 91892026-04-05 · 20:00 CT · Arie Crown Theater
    FLAURA-715: Tagrisso (osimertinib) 3L+ in NSCLC
    L. Paz-Ares, E. Winer · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  63. Abstract 97532026-04-01 · 21:00 CT · S406
    Real-world effectiveness of Imfinzi vs standard of care in SCLC
    L. Paz-Ares, M. Krop · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Small Cell📄🖼️
  64. Abstract 97222026-04-02 · 18:15 CT · S406
    PACIFIC-556: Imfinzi (durvalumab) maintenance in NSCLC
    L. Paz-Ares, J. Cortes, S. Modi, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  65. Abstract 93452026-04-04 · 16:30 CT · E450
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-825 study)
    N. Rizvi, J. Brahmer, S. Peters · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  66. Abstract e120652026-04-04 · 13:45 CT · S100A
    DESTINY-Breast-328: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    G. Curigliano, S. Tolaney, S. Peters · University of Chicago
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  67. Abstract 99502026-04-04 · 20:15 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-537
    M. Krop, J. Cortes, M. Reck, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  68. Abstract 91332026-04-01 · 16:30 CT · E450
    Long-term follow-up of Enhertu 2L for NSCLC: DESTINY-Breast-293
    S. Antonia, A. Spira, C. Saura, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  69. Abstract 94442026-04-01 · 13:15 CT · Arie Crown Theater
    Real-world effectiveness of Tecentriq vs standard of care in NSCLC
    S. Antonia, R. Herbst, F. Andre · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  70. Abstract 97332026-04-05 · 16:45 CT · E450
    Long-term follow-up of Imfinzi 3L+ for NSCLC: PACIFIC-213
    N. Rizvi, P. Schmid · Karolinska Institute
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  71. Abstract 99742026-04-01 · 14:45 CT · Hall B1
    KEYNOTE-840: Keytruda (pembrolizumab) 3L+ in SCLC
    S. Antonia, P. Schmid, M.C. Garassino, et al. · Memorial Sloan Kettering Cancer Center
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  72. Abstract 96062026-04-02 · 20:15 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-606 study)
    E. Winer, C. Robert, S. Peters · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  73. Abstract 95742026-04-05 · 19:45 CT · S100A
    FLAURA-925: Tagrisso (osimertinib) maintenance in NSCLC
    J. Cortes, E. Winer, N. Rizvi, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  74. Abstract 91612026-04-01 · 21:45 CT · Hall B1
    Real-world effectiveness of Enhertu vs standard of care in NSCLC
    S. Tolaney, C. Robert, C. Saura, et al. · Vall d'Hebron Institute of Oncology
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  75. Abstract 90142026-04-05 · 15:30 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-576
    J. Brahmer, E. Winer · Stanford Cancer Institute
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  76. Abstract 95772026-04-05 · 18:45 CT · Hall B1
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-558
    M.C. Garassino, S. Antonia, E. Winer · Karolinska Institute
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  77. Abstract 91062026-04-04 · 15:30 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-364
    S. Peters, E. Winer · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  78. Abstract 96932026-04-02 · 20:45 CT · Hall B1
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-260 study)
    J. Cortes, H. Borghaei, E. Winer, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  79. Abstract LBA4078LBA2026-04-05 · 18:00 CT · E450
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-806
    N. Rizvi, E. Winer, H. Rugo · Chinese University of Hong Kong
    Late-Breaking Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  80. Abstract 96042026-04-03 · 13:45 CT · Hall B1
    FLAURA-317: Tagrisso (osimertinib) adjuvant in NSCLC
    C. Robert, M.C. Garassino, M. Krop · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  81. Abstract 99442026-04-03 · 16:00 CT · S100A
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-803 study)
    S. Tolaney, G. Curigliano, R. Herbst, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  82. Abstract 98412026-04-02 · 20:00 CT · E450
    Long-term follow-up of Keytruda 2L for SCLC: KEYNOTE-238
    H. Rugo, A. Spira, E. Winer, et al. · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  83. Abstract 99672026-04-04 · 18:00 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-293 study)
    R. Herbst, G. Curigliano · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  84. Abstract 98932026-04-01 · 13:00 CT · S100A
    Long-term follow-up of Imfinzi 1L for SCLC: PACIFIC-902
    N. Rizvi, P. Schmid · Dana-Farber Cancer Institute
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  85. Abstract 99672026-04-03 · 18:15 CT · Hall B1
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-818
    M. Krop, E. Winer, N. Rizvi · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  86. Abstract 90252026-04-01 · 18:00 CT · Hall B1
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-262 study)
    P. Schmid, G. Curigliano, R. Herbst, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  87. Abstract 96512026-04-03 · 15:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-343 study)
    C. Robert, J. Cortes, H. Borghaei, et al. · Dana-Farber Cancer Institute
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  88. Abstract 97342026-04-01 · 19:30 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-710
    J. Brahmer, H. Borghaei, S. Antonia, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  89. Abstract 92502026-04-05 · 16:45 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-626
    A. Spira, M. Krop · Memorial Sloan Kettering Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  90. Abstract 94562026-04-02 · 21:45 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-561
    S. Tolaney, E. Winer, M. Reck, et al. · Peter MacCallum Cancer Centre
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  91. Abstract 95592026-04-01 · 14:30 CT · E450
    FLAURA-649: Tagrisso (osimertinib) 2L in NSCLC
    J. Brahmer, S. Peters · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  92. Abstract TPS80912026-04-04 · 16:00 CT · S100A
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-330
    P. Schmid, L. Paz-Ares, S. Tolaney · Johns Hopkins Kimmel Cancer Center
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  93. Abstract 90862026-04-03 · 18:30 CT · S100A
    KEYNOTE-204: Keytruda (pembrolizumab) adjuvant in NSCLC
    T. Mok, S. Modi, E. Winer, et al. · Chinese University of Hong Kong
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  94. Abstract LBA4093LBA2026-04-05 · 21:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-106 study)
    H. Rugo, M. Krop, R. Herbst, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Plenary SessionLung Cancer—Small Cell📄🖼️
  95. Abstract 98242026-04-02 · 15:45 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-315
    S. Tolaney, H. Borghaei, M. Krop, et al. · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  96. Abstract 95562026-04-02 · 19:00 CT · S100A
    Long-term follow-up of Imfinzi 1L for NSCLC: PACIFIC-339
    H. Borghaei, H. Rugo · Memorial Sloan Kettering Cancer Center
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  97. Abstract 93572026-04-05 · 18:00 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-600 study)
    M. Krop, H. Borghaei, A. Spira · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  98. Abstract 93732026-04-05 · 13:15 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-588 study)
    N. Rizvi, M.C. Garassino, R. Herbst, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  99. Abstract 94662026-04-01 · 13:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-45 study)
    M.C. Garassino, M. Krop, C. Robert, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  100. Abstract 97172026-04-05 · 20:00 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-842
    L. Paz-Ares, G. Curigliano, S. Peters, et al. · Vall d'Hebron Institute of Oncology
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  101. Abstract 96592026-04-02 · 19:00 CT · S100A
    FLAURA-574: Tagrisso (osimertinib) 1L in NSCLC
    N. Rizvi, R. Herbst, J. Brahmer · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  102. Abstract 95302026-04-02 · 20:45 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-195 study)
    L. Paz-Ares, C. Robert, S. Peters, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  103. Abstract TPS81022026-04-05 · 13:45 CT · Hall B1
    PACIFIC-750: Imfinzi (durvalumab) 1L in NSCLC
    S. Modi, A. Spira, N. Rizvi, et al. · Karolinska Institute
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  104. Abstract 96902026-04-02 · 16:15 CT · S406
    Long-term follow-up of Imfinzi 1L for SCLC: PACIFIC-868
    S. Tolaney, J. Cortes · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  105. Abstract 96052026-04-02 · 19:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-850 study)
    F. Andre, H. Rugo · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  106. Abstract 91732026-04-05 · 18:00 CT · S406
    FLAURA-297: Tagrisso (osimertinib) 2L in NSCLC
    E. Winer, M. Reck, N. Rizvi, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  107. Abstract 94422026-04-03 · 16:45 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-125
    L. Paz-Ares, F. Andre, M. Reck · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  108. Abstract 92032026-04-02 · 18:15 CT · E450
    Long-term follow-up of Imfinzi neoadjuvant for SCLC: PACIFIC-68
    S. Antonia, S. Tolaney, R. Herbst, et al. · Massachusetts General Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  109. Abstract 97292026-04-04 · 13:45 CT · Arie Crown Theater
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-127
    T. Mok, J. Brahmer, S. Antonia · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  110. Abstract 95192026-04-03 · 18:15 CT · E450
    Long-term follow-up of Enhertu neoadjuvant for NSCLC: DESTINY-Breast-934
    R. Herbst, T. Mok, C. Robert, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  111. Abstract 92242026-04-01 · 18:00 CT · S406
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-708
    S. Peters, P. Schmid, G. Curigliano · Mayo Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  112. Abstract 92892026-04-01 · 14:15 CT · Arie Crown Theater
    FLAURA-638: Tagrisso (osimertinib) neoadjuvant in NSCLC
    A. Spira, R. Herbst · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  113. Abstract 98082026-04-03 · 13:15 CT · S406
    PACIFIC-886: Imfinzi (durvalumab) adjuvant in NSCLC
    T. Mok, M.C. Garassino · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  114. Abstract 98162026-04-04 · 20:45 CT · S406
    IMpower-180: Tecentriq (atezolizumab) 3L+ in NSCLC
    R. Herbst, A. Spira · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  115. Abstract TPS81142026-04-03 · 15:00 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-260
    R. Herbst, L. Paz-Ares, T. Mok, et al. · Memorial Sloan Kettering Cancer Center
    Trials in Progress Poster SessionLung Cancer—Small Cell📄🖼️
  116. Abstract 99842026-04-01 · 16:00 CT · E450
    Long-term follow-up of Imfinzi maintenance for SCLC: PACIFIC-191
    P. Schmid, S. Peters, M. Reck, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  117. Abstract 94772026-04-05 · 21:30 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-873 study)
    S. Peters, N. Rizvi · Chinese University of Hong Kong
    Poster SessionLung Cancer—Small Cell📄🖼️
  118. Abstract 94672026-04-02 · 15:00 CT · S100A
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-293
    J. Cortes, S. Antonia · Chinese University of Hong Kong
    Poster SessionLung Cancer—Small Cell📄🖼️
  119. Abstract 95022026-04-01 · 14:30 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-96 study)
    J. Cortes, E. Winer, M.C. Garassino · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  120. Abstract 91622026-04-04 · 20:45 CT · S100A
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-976
    J. Cortes, P. Schmid, C. Saura, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  121. Abstract 90412026-04-03 · 21:45 CT · Hall B1
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-435
    J. Brahmer, M. Reck, M. Krop · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  122. Abstract 98312026-04-02 · 13:45 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-861
    P. Schmid, R. Herbst, T. Mok, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  123. Abstract e121222026-04-03 · 18:45 CT · S100A
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-165
    P. Schmid, S. Antonia · Princess Margaret Cancer Centre
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  124. Abstract 94092026-04-03 · 16:45 CT · Arie Crown Theater
    PACIFIC-286: Imfinzi (durvalumab) maintenance in SCLC
    H. Rugo, P. Schmid · MD Anderson Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  125. Abstract 99362026-04-05 · 13:45 CT · S100A
    Long-term follow-up of Imfinzi 3L+ for SCLC: PACIFIC-62
    C. Saura, H. Rugo · University of Chicago
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  126. Abstract 91102026-04-04 · 16:30 CT · Hall B1
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-745
    H. Borghaei, M. Krop, C. Saura, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  127. Abstract 94362026-04-03 · 21:00 CT · E450
    Long-term follow-up of Enhertu adjuvant for NSCLC: DESTINY-Breast-421
    M. Krop, S. Antonia, J. Brahmer, et al. · National Cancer Center Japan
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  128. Abstract 98232026-04-03 · 21:30 CT · E450
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-623
    L. Paz-Ares, S. Modi, H. Rugo · Peter MacCallum Cancer Centre
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  129. Abstract 91452026-04-04 · 14:15 CT · S406
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-271
    R. Herbst, M. Reck, E. Winer · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  130. Abstract 96592026-04-04 · 21:15 CT · E450
    IMpower-985: Tecentriq (atezolizumab) 1L in NSCLC
    N. Rizvi, M. Krop, A. Spira · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  131. Abstract 99802026-04-02 · 21:45 CT · S100A
    IMpower-267: Tecentriq (atezolizumab) adjuvant in NSCLC
    T. Mok, S. Peters, J. Cortes, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  132. Abstract LBA4131LBA2026-04-04 · 20:45 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-737
    M. Krop, J. Cortes, T. Mok, et al. · Chinese University of Hong Kong
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  133. Abstract 94232026-04-03 · 13:00 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-692
    H. Rugo, R. Herbst, J. Brahmer, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  134. Abstract 99302026-04-05 · 18:00 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-946
    F. Andre, M. Reck · Peter MacCallum Cancer Centre
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  135. Abstract 96472026-04-04 · 19:30 CT · E450
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-611
    S. Peters, C. Robert, T. Mok · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  136. Abstract 95212026-04-03 · 21:45 CT · S100A
    Long-term follow-up of Enhertu maintenance for NSCLC: DESTINY-Breast-809
    L. Paz-Ares, H. Rugo · Royal Marsden Hospital
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  137. Abstract 98932026-04-01 · 20:30 CT · S100A
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-916 study)
    H. Borghaei, J. Brahmer · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  138. Abstract 95672026-04-04 · 14:30 CT · E450
    FLAURA-116: Tagrisso (osimertinib) neoadjuvant in NSCLC
    S. Tolaney, S. Modi, C. Robert, et al. · Johns Hopkins Kimmel Cancer Center
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  139. Abstract 94712026-04-03 · 16:15 CT · Hall B1
    FLAURA-97: Tagrisso (osimertinib) 3L+ in NSCLC
    H. Rugo, G. Curigliano, J. Brahmer, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  140. Abstract TPS81392026-04-04 · 20:00 CT · Hall B1
    PACIFIC-960: Imfinzi (durvalumab) 1L in SCLC
    A. Spira, S. Modi, H. Rugo, et al. · Memorial Sloan Kettering Cancer Center
    Trials in Progress Poster SessionLung Cancer—Small Cell📄🖼️
  141. Abstract 94382026-04-04 · 21:45 CT · S406
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-35
    S. Antonia, T. Mok, M. Reck, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  142. Abstract 98972026-04-01 · 20:45 CT · S100A
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-502
    H. Rugo, E. Winer, G. Curigliano, et al. · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  143. Abstract 96382026-04-05 · 20:15 CT · E450
    IMpower-777: Tecentriq (atezolizumab) 3L+ in NSCLC
    S. Modi, H. Rugo, C. Robert, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  144. Abstract 92752026-04-03 · 16:30 CT · Arie Crown Theater
    KEYNOTE-258: Keytruda (pembrolizumab) 3L+ in SCLC
    N. Rizvi, F. Andre, T. Mok, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  145. Abstract 99432026-04-03 · 20:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-789 study)
    A. Spira, T. Mok, P. Schmid, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  146. Abstract 94882026-04-01 · 21:15 CT · E450
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-175 study)
    E. Winer, P. Schmid · Karolinska Institute
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  147. Abstract 91332026-04-01 · 15:30 CT · Hall B1
    FLAURA-820: Tagrisso (osimertinib) adjuvant in NSCLC
    A. Spira, H. Borghaei, F. Andre, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  148. Abstract 96602026-04-04 · 13:15 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-835 study)
    S. Modi, S. Tolaney, P. Schmid · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  149. Abstract LBA4148LBA2026-04-02 · 13:00 CT · E450
    Long-term follow-up of Imfinzi neoadjuvant for NSCLC: PACIFIC-819
    M. Reck, M. Krop, H. Borghaei, et al. · Institut Gustave Roussy
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  150. Abstract 90022026-04-04 · 16:45 CT · Arie Crown Theater
    PACIFIC-975: Imfinzi (durvalumab) 3L+ in NSCLC
    H. Rugo, C. Saura, A. Spira, et al. · Mayo Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  151. Abstract 95642026-04-05 · 21:30 CT · Hall B1
    CheckMate-909: Opdivo (nivolumab) 3L+ in NSCLC
    S. Peters, N. Rizvi · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  152. Abstract 91872026-04-03 · 19:45 CT · Hall B1
    Long-term follow-up of Imfinzi neoadjuvant for NSCLC: PACIFIC-44
    R. Herbst, A. Spira, G. Curigliano, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  153. Abstract TPS81522026-04-04 · 14:45 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-679
    C. Robert, M. Reck · UCSF Helen Diller Family Comprehensive Cancer Center
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  154. Abstract 92452026-04-03 · 19:00 CT · S406
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-600 study)
    J. Cortes, T. Mok, S. Tolaney, et al. · Stanford Cancer Institute
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  155. Abstract 96972026-04-05 · 16:00 CT · S406
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-395
    S. Antonia, H. Borghaei, J. Brahmer, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  156. Abstract 99702026-04-04 · 15:45 CT · Hall B1
    FLAURA-100: Tagrisso (osimertinib) adjuvant in NSCLC
    R. Herbst, S. Tolaney · Dana-Farber Cancer Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  157. Abstract 97102026-04-03 · 18:45 CT · Hall B1
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-42
    F. Andre, S. Tolaney, M. Krop, et al. · Royal Marsden Hospital
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  158. Abstract 95202026-04-03 · 16:30 CT · S100A
    PACIFIC-718: Imfinzi (durvalumab) neoadjuvant in SCLC
    R. Herbst, M.C. Garassino, S. Antonia, et al. · Peter MacCallum Cancer Centre
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  159. Abstract 90812026-04-02 · 15:45 CT · S406
    KEYNOTE-912: Keytruda (pembrolizumab) 3L+ in SCLC
    M. Krop, T. Mok, J. Brahmer, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  160. Abstract 93292026-04-05 · 19:45 CT · S100A
    Long-term follow-up of Tecentriq maintenance for NSCLC: IMpower-569
    G. Curigliano, H. Rugo, C. Robert · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  161. Abstract 90832026-04-05 · 18:15 CT · Arie Crown Theater
    DESTINY-Breast-612: Enhertu (trastuzumab deruxtecan) 3L+ in NSCLC
    J. Cortes, M. Reck, G. Curigliano, et al. · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  162. Abstract 96692026-04-03 · 16:45 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-889 study)
    G. Curigliano, H. Borghaei, P. Schmid, et al. · Mayo Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  163. Abstract 91662026-04-02 · 19:15 CT · E450
    Long-term follow-up of Imfinzi 1L for SCLC: PACIFIC-772
    C. Robert, S. Peters, A. Spira, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  164. Abstract 95992026-04-01 · 15:45 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-454
    C. Saura, L. Paz-Ares, J. Brahmer, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  165. Abstract 93102026-04-02 · 21:30 CT · S406
    PACIFIC-642: Imfinzi (durvalumab) 1L in NSCLC
    T. Mok, C. Saura, E. Winer · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  166. Abstract 99782026-04-05 · 13:45 CT · Hall B1
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-861
    A. Spira, M. Krop, N. Rizvi, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  167. Abstract 98512026-04-01 · 19:15 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-722
    M. Reck, C. Saura, A. Spira, et al. · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  168. Abstract 99942026-04-01 · 16:00 CT · E450
    Long-term follow-up of Tecentriq 3L+ for NSCLC: IMpower-638
    R. Herbst, S. Modi, C. Saura, et al. · Chinese University of Hong Kong
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  169. Abstract 96122026-04-03 · 14:30 CT · S100A
    Long-term follow-up of Opdivo 2L for NSCLC: CheckMate-495
    P. Schmid, A. Spira, G. Curigliano, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  170. Abstract 98812026-04-05 · 20:45 CT · E450
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-162
    M.C. Garassino, P. Schmid, S. Tolaney, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  171. Abstract 98832026-04-02 · 19:30 CT · Hall B1
    IMpower-392: Tecentriq (atezolizumab) 3L+ in NSCLC
    S. Tolaney, P. Schmid, M.C. Garassino, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  172. Abstract 93722026-04-04 · 16:00 CT · E450
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-348 study)
    M. Reck, E. Winer, H. Rugo · Dana-Farber Cancer Institute
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  173. Abstract 93282026-04-04 · 20:45 CT · S100A
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-430
    N. Rizvi, J. Brahmer, S. Modi, et al. · Karolinska Institute
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  174. Abstract 98582026-04-03 · 15:45 CT · S406
    Quality of life outcomes with Tecentriq in patients with NSCLC
    F. Andre, J. Brahmer, L. Paz-Ares, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  175. Abstract 97192026-04-02 · 21:00 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-995
    M.C. Garassino, G. Curigliano, C. Saura, et al. · Massachusetts General Hospital
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  176. Abstract LBA4175LBA2026-04-02 · 14:15 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi 2L for SCLC: PACIFIC-640
    M. Reck, J. Brahmer, L. Paz-Ares · MD Anderson Cancer Center
    Late-Breaking Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  177. Abstract TPS81762026-04-05 · 19:30 CT · Hall B1
    DESTINY-Breast-408: Enhertu (trastuzumab deruxtecan) 1L in NSCLC
    A. Spira, J. Brahmer, H. Borghaei · Peter MacCallum Cancer Centre
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  178. Abstract 98502026-04-04 · 21:30 CT · Hall B1
    KEYNOTE-842: Keytruda (pembrolizumab) maintenance in NSCLC
    F. Andre, T. Mok · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  179. Abstract 96812026-04-04 · 16:30 CT · S100A
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-885
    S. Tolaney, J. Cortes · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  180. Abstract 98092026-04-05 · 13:15 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-555
    J. Cortes, P. Schmid · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  181. Abstract 97972026-04-03 · 16:30 CT · Hall B1
    Long-term follow-up of Imfinzi neoadjuvant for NSCLC: PACIFIC-970
    C. Saura, M.C. Garassino, A. Spira, et al. · Memorial Sloan Kettering Cancer Center
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  182. Abstract 99322026-04-02 · 16:00 CT · Arie Crown Theater
    FLAURA-461: Tagrisso (osimertinib) adjuvant in NSCLC
    P. Schmid, M.C. Garassino, C. Saura · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  183. Abstract 91522026-04-05 · 21:30 CT · S100A
    Long-term follow-up of Keytruda 3L+ for NSCLC: KEYNOTE-708
    H. Borghaei, P. Schmid, E. Winer, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  184. Abstract 92272026-04-05 · 19:15 CT · S100A
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-601 study)
    S. Tolaney, M.C. Garassino, P. Schmid, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  185. Abstract 99202026-04-04 · 13:45 CT · Hall B1
    Long-term follow-up of Imfinzi maintenance for NSCLC: PACIFIC-467
    A. Spira, S. Antonia, J. Brahmer, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  186. Abstract 90142026-04-03 · 18:00 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-751 study)
    C. Robert, F. Andre · Chinese University of Hong Kong
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  187. Abstract 90972026-04-02 · 13:00 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-26 study)
    F. Andre, N. Rizvi, C. Robert · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  188. Abstract 98072026-04-04 · 21:45 CT · Arie Crown Theater
    PACIFIC-694: Imfinzi (durvalumab) neoadjuvant in SCLC
    L. Paz-Ares, J. Brahmer, P. Schmid, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  189. Abstract 90242026-04-03 · 21:45 CT · Hall B1
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-276
    C. Saura, P. Schmid, L. Paz-Ares, et al. · Karolinska Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  190. Abstract 90372026-04-05 · 15:15 CT · Hall B1
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-881 study)
    H. Rugo, R. Herbst, C. Robert, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Small Cell📄🖼️
  191. Abstract 92822026-04-02 · 14:00 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-231
    H. Borghaei, T. Mok · MD Anderson Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  192. Abstract 93032026-04-03 · 15:15 CT · S100A
    KEYNOTE-731: Keytruda (pembrolizumab) maintenance in NSCLC
    M.C. Garassino, S. Antonia, L. Paz-Ares, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  193. Abstract 92482026-04-01 · 13:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-801 study)
    S. Tolaney, J. Cortes · Cleveland Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  194. Abstract 93932026-04-05 · 15:15 CT · Arie Crown Theater
    FLAURA-696: Tagrisso (osimertinib) neoadjuvant in NSCLC
    M. Reck, S. Antonia · Chinese University of Hong Kong
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  195. Abstract 95802026-04-03 · 15:30 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-609 study)
    P. Schmid, S. Antonia, M. Krop · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  196. Abstract 91992026-04-05 · 18:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-911 study)
    G. Curigliano, N. Rizvi, L. Paz-Ares, et al. · Princess Margaret Cancer Centre
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  197. Abstract 98922026-04-01 · 21:45 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-269
    M. Krop, G. Curigliano, S. Modi, et al. · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  198. Abstract 99972026-04-04 · 13:15 CT · S100A
    IMpower-515: Tecentriq (atezolizumab) maintenance in NSCLC
    S. Peters, J. Cortes · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  199. Abstract 98522026-04-05 · 15:45 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-582 study)
    M. Reck, H. Rugo, M. Krop · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  200. Abstract 91012026-04-02 · 13:30 CT · E450
    FLAURA-493: Tagrisso (osimertinib) neoadjuvant in NSCLC
    S. Tolaney, C. Saura, S. Modi · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.